3 research outputs found
Microvascular dysfunction in pediatric patients with SARS-COV-2 pneumonia: report of three severe cases
The coronavirus 19 (COVID-19) pandemic has affected hundreds of millions of people worldwide: in most of cases children and young people developed asymptomatic or pauci-symptomatic clinical pictures. However authors have showed that there are some categories of childhood more vulnerable to COVID-19 infection such as newborns or children with comorbidities. We report for the first time to the best of our knowledge about microvascular dysfunction in three pediatric clinical cases who developed COVID-19 infections with need of pediatric critical care. We found that sublingual microcirculation is altered in children with severe COVID-19 infection. Our findings confirmed most of data already observed by other authors in adult population affected by severe COVID-19 infection, but with distinct characteristics than microcirculation alterations previous observed in a clinical case of MIS-C. However we cannot establish direct correlation between microcirculation analysis and clinical or laboratory parameters in our series, by our experience we have found that sublingual microcirculation analysis allow clinicians to report directly about microcirculation dysfunction in COVID-19 patients and it could be a valuable bedside technique to monitor thrombosis complication in this population
Pharmacogenetics in critical care: association between CYP3A5 rs776746 A/G genotype and acetaminophen response in sepsis and septic shock
Background
Pharmacogenetics could represent a further resource to understand the interindividual heterogeneity
of response of the host to sepsis and to provide a personalized approach to the critical care patient.
Methods
Secondary analysis of data from the prospective observational study NCT02750163, in 50 adult septic and
septic shock patients treated with Acetaminophen (ACT) for pyrexia. We investigated the presence of two polymorphisms, located respectively in the genes UGT1A1 and CYP3A5, that encode for proteins related to the hepatic
metabolism of ACT. The main dependent variables explored were plasmatic concentration of ACT, body temperature
and hepatic parameters.
Results
8% of the patients carried CYP3A5 rs776746 A/G genotypes and showed signifcantly higher plasma levels of
ACT than GG wild type patients, and than patients with UGT1A1 rs8330 C/G genotypes.
Conclusions
Identifying specifc genotypes of response to ACT may be helpful to guide a more personalized titration of therapy in sepsis and septic shock. CYP3A5 might be a good biomarker for ACT metabolism; however further
studies are needed to confrm this result